{
  "report_rows": [
    {
      "kpi": "Total revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$8.700B vs. cons $8.681B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.510 vs. cons $0.506",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "EBITDA",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.800B vs. cons $1.784B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 Middle East recovery / activity",
      "prediction": "UNKNOWN",
      "answer": "guide ~gradual recovery vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "FY26 capital investments",
      "prediction": "UNKNOWN",
      "answer": "guide ~$2.5B vs. cons UNVERIFIED",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Digital EBITDA margin",
      "prediction": "UNKNOWN",
      "answer": "guide >=35% vs. cons UNVERIFIED",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": 3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 relief on a de-risked setup, but limited by no expected FY re-guide",
  "day5_confidence": "LOW"
}